Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Early Diagnosis of Pediatric Crohn’s Disease - Pointing Problems and Suggestions
Maraci Rodrigues
Pediatric Gastroenterologist, Department of Gastroenterology, School of Medicine University of
Sao Paulo, Brazil
Email: [email protected]
Chapter 3
Inflammatory Bowel Disease
1. Introduction
Inflammatoryboweldisease(IBD)includesCrohn'sdisease(CD)andulcerativecolitis(UC)andcanbediagnosedinchildhoodandadolescencein25%ofcases[1].ChildrenthatcontractIBDbefore10yearsofagealmostalwayspresentwithextensivecolitisthatcannotbeclassifiedaseitherUCorCD,andremaincolitisnotdetermined(IBD-U)untilseveralyearslater[2].
Data from the literatureon the timeofdiagnosisvaryconsiderably.Apediatric IBDstudyinGermanyfoundthattheaveragetimeforCDdiagnosiswas5months(2-10months),fortheUCwas3months(1-6months)andIBD-Uwas4months(2-11months)andthegrowthdeficitwasthemostcommonsignincaseswithlatediagnosis[3].Comparedtothisstudy,thetimeintervalbetweentheonsetofsymptomsandthediagnosiswas4and2monthsinarecentFrenchstudy(EPIMAD)[4,5]and4monthsinNoroega[5],10and6monthsinItaly[6]re-spectivelyforCDandUC.
TheEuropeanstudygrouprecentlypublishedtherecordofnewdiagnosesofpediatricIBD,EuroKidsaged0-18yearsbetweentheyears2004-2009.Thisstudygatheredin2087patients,ofwhich59%werediagnosedwithCD,32%withUCand9%asIBD-U.Themeanageatdiagnosiswas12.1years(0.6-17,9years),and56%boys[7].
Pediatriciansshouldbecomefamiliarnotonlywiththetypicalbutalsoatypicalpresen-tationsofIBDbecause22%ofchildrenpresentwithgrowthfailure,anemia,perianaldisease,orotherextra-intestinalmanifestationsofthepredominantonlyinitialfeature.Adetailedfam-
InflammatoryBowelDisease
2
www.openaccessebooks.comRodriguesM
ilyhistoryshouldbeobtainedbecause20%ofchildrenwithIBDhaveanaffectedrelative[2].
ThissectionwillbediscussedthediagnosisofpediatricCD.
2. Gastrointestinal Manifestations in Children and Adolescents With CD
TheclinicalmanifestationsofCDdependonthesiteofaffectedbowel,ifitisintheuppergastrointestinaltract,thesmallintestineorcolon,inthelattercasesimulatingUC.Thehighlightof theclinicalmanifestationsofCDis thepresenceofabdominalpainassociatedwithwarningsignssuchasfever,growthretardation,pubertaldelay,weightloss,pallorandperianalinvolvement(fistulas,fissuresandabscesses).Sometimes,thepicturebeginsacutelywithsymptomsofinflammatoryacuteabdomen,mimickingacuteappendicitis.Pediatricpa-tientswithCDexhibitmoreilealdiseaseattheonsetofdiseasethanadult.Throughoutevolu-tion,complicationsmayoccurasstricturebowelloopsmanifestedwithsymptomsofocclu-sionorentero-enteric,enterocutaneous,perianalfistulasorfistulasbetweenbowelloopsandadjacentorganssuchasthebladderandgenital[1,2,8].
Thegrowthdeficit thatprecedesthediagnosis is thebiggestdifferencein thechild’spresentationofCDwhencomparedtoadults.ThedelayofpubertyanddecreasedfinaladultstaturecanoccurwhenthediseaseoccursinadolescenceandthereisdelayinthediagnosisofCD.Furthermore,persistenceofthegrowthdeficiencymaybetheonlysignaltothediagnosisanddiseaseactivity,notonlyinperformancebutduringthecourseofdisease[1.2].
ToevaluatetheseaspectsofpediatricCD,weprospectivelyselected22patientswithmildly tomoderatelyactiveCD,29patientswith inactiveCDand35controls,undergoingregulartreatmentattheClinicalGastroenterologyOutpatientClinicaloftheUniversityofSaoPauloSchoolofMedicineHospitaldasClinicas,SaoPaulo,Brazil.Themeanvaluesforleanbodymass,Tannerstage,height-for-ageZscoreandBMI-for-ageZscorewerelowerintheactiveCDgroupthanintheinactiveandcontrolgroups(p<0.05forboth).Whencomparedindividually,2(9.1%)ofthepatientswithactiveCDand1(3.4%)ofthosewithinactiveCDhadshortstature(height-for-ageZscore<-2).Inaddition,7(31.8%)ofthepatientswithactiveCDand3(10.3%)ofthosewithinactiveCDweremalnourished(BMI-for-ageZscore<-2).Itisofnotethatsome(4.2%)ofourCDpatientshadaBMI-for-ageZ-score>2standarddesvia-tion[9].
ItisimportanttonotethattheveryearlyonsetofIBD(youngerthan2yearsoflife),ischaracterizedbysevereprogressivecolitis thatcanstartbeforethreemonthsoflifewithfailure to thrive,extensivecolonic inflammation,perianal involvement,arthritis, folliculitisusuallynotcompromisingthesmallbowel,imposingdifferentialdiagnosiswithmonogeneticsdisease[10,11,12,13].Table 1summarizesthemaindifferencesoftheclinicalpicturebetween
InflammatoryBowelDisease
3
CDandUC.Tabel 1:PercentageofClinicalPresentationInflammatoryBowelDiseaseinChildrenandAdolescents.
Presenting SymptomCrohn disease (% of patients)
Ulcerative Colitis
(% of patients)
General
Weightloss 55-80 31-38
Fever 38 NA
Anorexia 2-25 6
Growthretardation 3-4 0
Lethargy 13-27 2-12
Gastrointestinal tract
Abdominalpain 67-86 43-62
Diarrhea 30-78 74-98
Rectalbleeding 22-49 83-84
Nausea/vomiting 6 <1
Constipation 1 0
Perianaldisease 6-15 0
Mouthulcers 5-28 13
Abbreviations: NA:notapplicable.RangearederivedfromdatareportedbyKugathasanetal[14],Grif-fiths[15]andSawczenkoandSandhu[16].3. Extra-Intestinal Manifestations in Children and Adolescents with CD Despiteitsname,IBDisnotlimitedtotheintestineandabout30%ofpatientsdevelopapreviousextra-gastrointestinalmanifestationorduringevolutionoftheirdisease[17].Theextra-intestinalmanifestationsofIBDcanbedividedintoafewcategories:
•Relatedcolitis(skin,eyes,jointsandmouth)thatoccurinparallelwithdiseaseactivity
•Hepatobiliary
•Decelerationofgrowth
•Secondarycomplicationsofthedisease(nephrolithiasis,obstructiveuropathy,andgallstonepancreatitis)
•Otherevents,whichdonotmeetanypreviouscriteria(amyloidosis,cancer,vascular,hema-tologic,pulmonary,cardiacandneurological)
Table 2 summarizes the main extra-intestinal manifestations in IBD in children andadolescents
InflammatoryBowelDisease
4
4. Differential Diagnosis
Theclinicalpresentationofmucousandbloodydischargediarrheamaycoverseveraletiologies[1,2,8]:
•InfectiousColitis(Salmonella,Shigella,Yersinia,Campylobacter,Aeromonas,Mycobacte-riumtuberculosisandEntamoebahystolitic)
•Pseudomembranouscolitis(Clostridiumdifficile)
•Hemolyticuremicsyndrome(Escherichiacoli0157:H7)
•Parasitic(amebiasis,strongyloidiasis)
•Viral(cytomegalovirusandherpessimplex)
•Vasculitis(Henoch-SchönleinandBehcet'sdisease)
•FamilialMediterraneanFever(autosomalrecessivedisease)
•AcquiredImmunodeficiencySyndrome(AIDS)
•PrimaryImmunodeficiency
Table 3summarizesthemainsymptomsandalarmsignalstotheprimaryimmunodeficiency
Extra-intestinal manifestationPrevalence in
CD(% of patients)
Prevalence in UC
(% of patients)
Pyodermagangrenosum CR*
Joints/arthritis ----- 3.8
Osteoporosisandosteopenia 8-41 24-25
Growthdelay 81 28
Nephrolithiasis CR 3.2
Autoimunehepatitis ----- 1.3
Uveitis ----- 0.63
Amyloydosis CR
Vasculardamage 4.2 0.63
Pancreatitis 3.9 2.5
Anemia 69 40.5
Table 2:PrevalenceofintestinalmanifestationsinchildrenandadolescentswithIBD
*ExceptwherenotedbyCR(casereport)CDtotalNinchildrenrangesfrom21to26andUCtotalNrangesfrom21to158.Datafrom:JoseFAandHeymanMB[17].
InflammatoryBowelDisease
5
Thechildrenwithrectalbleedingcanpresentulcerativeproctitis,whichmustbedif-ferentiatedfromothercauses,suchasanalfissure,hemorrhoids,polyps,anddependingontheintensityoftheintestinalbleeding,Meckel'sdiverticulum[1,2,8].
Inchildrenwithpaininthelowerrightquadrantshouldbeexcludedacuteappendicitispossibilities,tuberculosisandlymphoma.Inpatientswithabdominalabscess,thedifferentialdiagnosis includesappendixorperforatedvasculitisand trauma. Inadolescents, should re-memberthegynecologiccauses.
Moreover, it isnecessary todifferentiate theCD fromUC,not alwayspossible taskwhenonedoesnothavedefinitivepathologicfindingsofeachdisease,stayingforsometimeColitisdenominationnotdetermined(IBD-U)in15%ofcases[18].
Whenrecurrentabdominalpainisthemainsymptominchildren,itshouldbeconsid-ered thepossibilityofdealingwithfunctionalgastrointestinaldisease(FGID),especially ifthereisintestinalandextra-intestinalsymptomsunspecific.Thus,theidentificationofcriticalfeaturesor"redflags"canhelppediatriciansrecognizethepatientwithFGIDabdominalpainorCD,avoidingtestsunnecessarydiagnosesinpatientswithFGIDandontheotherhand,topreventthedelaydiagnosisofCD[19].
InthestudybyEl-ChammasetalcharacteristicsofabdominalpainpatientFGIDweredistinctfromabdominalpaininpatientswithCD:(1)greaterstressreportsandheadache(p<0.001),(2)higherprevalenceofFGIDinfamily(irritablebowelsyndromeorconstipation,p<0.05) and (3) lower reporting hematochezia,weight loss, difficulty gainingweight andgreaterpresenceofvomiting(p<0.05).However,wakingupatnightandjointpaindidnotdifferbetweenthetwogroups.Incontrast,thepresenceofanemia,hematochezia,andweightlosswasmorepredictiveofCD(sensitivity94%)[19].
Positivefamilyhistoryofprimaryimmunodeficiency
Consanguineousparentsor>2familymemberswithearly-onsetIBDInfantile(<2years)IBD
Severe,therapy-refractaryIBD,particularlywithperianal/rectovaginaldisease/abscesses
Recurrentinfectionsintheabsenceofimmunosuppressantdrugs(particularlypulmonarydiseaseandskinabscesses)
Neutropenia,thrombocytopenia,orabnormalimmunestatus(Iglevels)intheabcenseofimmunosuppressantdrugs
Naildystrophyandhairabnormalities(trichorrhexisnodosa)
Skinabnormalities(congenitaleczema,albino)
Table 3:Alarmsignsandsymptomsforprimaryimmunodeficiency
Abbreviations: IBD:inflammatoryboweldisease;Ig:immunoglobulin.Datafrom:Levineetal[1]
InflammatoryBowelDisease
6
5. Diagnostic approach of CD in children and adolescents
5.1. Clinical symptoms
ThediagnosisofIBDconsistsofafewsteps,startingfromtheinitialclinicalsuspicionpediatrician,basedonclinicalsymptomsandphysicalexaminationwiththereferralofsus-pectedcasestothePediatricGastroenterologist[1,2].
5.2. Physical exam
Theprevioushistorydataofheightandweightareessentialfordetectingdecelerationofthegrowthrateandweightloss.Furthermore,itshouldbeobservedifthereisthepresenceofdelayedpubertaldevelopmentbyTannerscale[20].
Examinesthecolorofmucousmembranestodetectpallor(anemia),clubbingoffingernailsandwatchglass(presentinchronicdisease).Theoralexaminationmayshowaphthousulcers,angularcheilitisandtonguewithareductionofthepapillae(irondeficits,vitaminB12,folicacid,zinc,etc.).Skinchangesshouldberecorded(vitiligo,erythemanodosumandpyo-dermagangrenosum).
Examinationoftheabdomenmayshowthetensewall,painful,andthepresenceofmass(suggestiveofileocecalabscessorinfiltration).Theevaluationofthejointscanfindsignsoflowbackpain,arthritisorsacroiliitis.Theanalareashouldbeinspectedtodetectfissure,fis-tulasandperianalabscessesaremorecommoninCD[1,2].
6. Laboratory tests
Initially,theymustberejectedmajordiseasesthatmimicIBDthroughexams:
•Feces:stoolcultureandtestingfortoxinAandBofClostridium difficile,totheexclusionofothercausesofcolitis
•Testofthepurifiedproteinderivativeoftuberculin(PPD,purifiedproteinderivativeoftuber-culin)towardofftuberculosis
•GeneralImmunologicalevaluationtoruleoutthepresenceofprimaryimmunodeficiencies
•SerologyforAIDS
Afterthisinitialstep,asktolaboratorytestsrelatedtoinflammation,suchaserythrocytesedimentation,C-reactiveprotein(CRP),platelet,acidalpha-1-glycoprotein;iftheresultsarehigh,reinforcingthediagnosisofIBD.Oneshouldalsoaskcellbloodcount(CBC),withat-tentiontothepresenceofhypochromicanemiaandleukocytosis;andirondosingandproteinelectrophoresisfordetectionofirondeficiencyandsecondarylossorhypoalbuminemiadid
InflammatoryBowelDisease
7
notabsorbedbyinflamedintestinalmucosa.Amongtheserumelectrolytes,themostcommonisthehypokalemiaagainstattributedtochronicdiarrhea[1,2].
ThepatientwillbereferredtothepediatricgastroenterologistfordefinitivediagnosisofIBD.
Somenon-invasivelaboratorytestscanincreasetheCDdetectionprobability,suchaslactoferrinandcalprotectininthefaeces[21].
According to the study-levelmeta-analysis, inhigh-prevalencecircumstances, faecalcalprotectincanbeusedasanoninvasivebiomarkerofpediatricIBDonlywithasmallriskofmissingcases,anditcanhelpinselectingpatientsforendoscopicevaluationandhasthehighoverall sensitivityand thespecificity fordiagnosingIBD[22].Anotherapplicationof thismethodwasthedifferentiationbetweenfunctionaldiseaseandIBD[23].
TheuseofserologicalmarkersinchildrenwithsuspectedIBDisanoninvasivetestap-plicationattemptstoshortenthediagnosis,differentiatetheCDfromUCandcorrelatesthemtoprognosisofthedisease.ManyantibodiesagainstmicrobialcomponentsarefoundinCD,includingtheantibodyagainstoutermembraneporin-CEscherichia coli(antiOmpC),againstthesequenceI2associatedPseudomonas(anti-I2)andagainstbacterialCBir1flagina(anti-CBir1).Itwasfoundtheprevalenceof11%and56%ofanti-anti-OmpCandI2respectivelyinchildrenwithCD,withdifferencesaccordingtoageatdiagnosis.Othermarkersareanti-glicanantibodies,resultsfromtheinteractionbetweenimmunecellsandglycosylatedcellwallcomponentsoffungi,yeast,andbacteriaarefoundinCD:mannobiosideanti-carbohydrateantibodies (AMCA), anti-laminaribiose carbohydrate antibodies (FTAA), anti-carbohydrateantibodies chitobioside (ACCA), antilaminarim carbohydrate antibodies (anti-L), and anti-chitin(anti-C)carbohydratesantibodies.Only16.9%-30.5%ofpatientswerepositiveforeachoftheninpediatricCD[24].
Anti-glicoprotein2(GP2)IgGandIgA,constitutingnovelCDspecificautoantibodies,appearstobeassociatedwithdistinctdiseasephenotypesIdentifyingpatientsatayoungerage,withileocoloniclocation,andstructuringbehaviorwithperianaldisease[25].
Dosagesofliverenzymes,bilirubinandamylaseareintendedtodetectliverandpan-creaticinvolvementinIBD,thediseaseitselforsecondarytotheuseofdrugstotreatthedis-ease.
Recentmeta-analysisdeterminedtheaccuracyofdiagnosissymptoms,signs,noninva-sivetests,andtestcombinationsthatcanassisttheclinicianwithdiagnosisofIBDinsymp-tomaticchildren.Theconclusionswerechildreninthesymptomsarenotaccurateenoughtoidentifylow-riskpatients inwhomanendoscopycanbeavoided.AssessmentoffecalCal-
InflammatoryBowelDisease
8
protectin(FCAL),C-reactiveprotein(CRP),andalbuminfindingsarepotentiallyofclinicalvalue,giventheirabilitytoselectchildrenatlowrisk(negativeFCALtestresult)orhighrisk(positiveCRPoralbumintestresult)isIBD[26].
One such promising test, the polymorphonuclearCD64 index capitalizes on inflam-mation-inducedexpressionofFcyreceptorI(CD64markers)onneutrophilsandhasahighsensitivityandspecificityforCDinchildren[27].
NormallaboratoryevaluationresultdoesnotexcludethediagnosisofIBDbecauseap-proximately10%to20%ofchildrenwithIBDwillhavestandardlaboratoryresults[28].IfitpersiststhesuspecteddiagnosisofIBD,evenwithregularscreeningtests,shouldcontinuetheinvestigation,requestingtoupperandlowerendoscopywithserialbiopsies.
6.1. Endoscopy
UpperendoscopyandileocolonoscopywithserialbiopsiesofthedifferentsegmentsofthedigestivetractarethetestsconsideredthegoldstandardforthediagnosisofCD,anddefi-nitelyexcludesotherviral,bacterialandfungaletiologies.MacroscopiccharacteristicsoftheluminalpediatricuntreatedDCaresummarizedinTable 4.
6.2. Histology
EarlymanifestationsofpediatricIBDcanberelativelynonspecific.Initialmucosalbi-opsiesmaynotbeconclusive,delayingthediagnosisuntilsubsequentbiopsiestypicalhisto-logicfeaturesofIBD.
IncontrasttothefindingsofIBD,acuteself-limitedcolitis(CALA)doesnotshowthearchitecturaldistortionofthecrypt,basallinfoplasmocitoseandPanethcellmetaplasia.Thecombinationofthreeparameters-increaseofplasmacellsinthelaminapropria,cryptdis-tortionandatrophy-represents94%sensitivityand96%specificitytodistinguishIBDfromothernon-specificcolitis[18].
InarecentstudyinvestigatingpotentialofearlyhistologicmarkersofpediatricIBD,theauthorsconcludedthatthedistortionofcoloniccrypts,gastritisandtheaveragedensityofeosinophilsintherectosigmoidwereincreasedsignificantlyintheIBDgroupcomparedtothegroupwithfunctionalabdominalpain.Immunohistochemistrystainingfortumornecrosisfactor-αandmatrixmetalloproteinase-9wasperformedonthestomachandrectosigmoidareasdidnotrevealanysignificantdifferencesbetweenthegroupsoftheinitialendoscopicevalua-tion[29].
Microscopic characteristics of the luminal pediatric untreatedCDare summarized inTable 4.
InflammatoryBowelDisease
9
6.3. Radiology
Theimagingmethodfortheevaluationofthesmallintestineisveryimportanttoevalu-atetheextentofdisease,assesstheseverity,differentiatebetweenCDandUC,andidentifycomplicationssuchasfistulae,abscessesandintestinalstrictures.Thecurrenttrendistore-placetheintestinaltransitbyComputedTomographyEnterography(CTE)orMagneticRes-sonanceEnterography(MRE).Bothtechniquesprovideaperfectimageenterographyofthelumenandwallstructuresadjacenttotheintestine.MREadvantagesarethesuperiorcontrastresolutionandthelackofionizingradiation,althoughitispossibletomaintainthequalityoftheimagebyCTEthroughinteractiveimagereconstruction[30].SomepediatricMREproto-colsareavailableradiologicalstudiesshouldincludeMagneticResonancePelvictoevaluatecasesaccompaniedbyperianalabscessesandfistulas[31].
7. Further investigation
TherealizationofEndoscopyCapsuleisauthorizedbytheFoodandDrugAdministra-tion(FDA)intheUSforchildrenabove10years,buttherearereportsofchildrenyoungerthanheldthisdiagnosticmethodbyintroducingthecapsuleendoscopically.Thistestallowsevaluationoftheentiresmallbowelmucosa,andisusefulinchildrenwithpersistenthighdi-
Table 4:MacroscopicandmicroscopicfeaturesofDCpediatricluminaluntreated.
Typical macroscopic findings of CD Typical microscopic findings of CD
MucosalaphthousulcersNoncaseatinggranuloma(s)-mustberemotefrom
rupturedcrypt
LinearorserpentineulcerationFocalchronicinflammation,transmural
inflammatoryinfiltrate,submucosalfibrosis
Cobblestoning
Stenosis/structuringofbowelwithprestenoticdilatation
Nonspecific microscopic findings of CD
Imagingousurgical-bowelwallthickeningwithluminalnarrowing
Granulomaadjacenttorupturedcrypt
Perianallesions-fistula(s),abscesses,analstenosis,andcanalulcers,largeandinflamed
skintags
Mildnonspecificinflammatoryinfiltrateinlaminapropria
Skiplesions Mucosalulceration/erosion
JejunalorilealulcersSignsofchronicity(eg.cryptarchitecturalchanges,colonicPanethcellmetaplasiaandgobletcell
depletion)
NonspecificmacroscopicfindingsofCD:oedema,erythema,friability,granularity
Exudate:lossofvascularpattern,isolatedaphthousulcers,perianallesions-midlineanal
fissures,smallskitags
Abbreviations:CD:Crohndisease.ModificationofLevineAetal[1].
InflammatoryBowelDisease
10
Table 5:ParisClassificationforCrohn'sdisease
Age Diagnosis •A1a:0-aged<10years•A1b:10-<17years
Location •L1:1/3distalileum±limitedtothececum•L2:Colonic•L3:ileocolônica•L4A:TGIproximaltothehighangleofTreitz•L4B:TGIhighdistaltoTreitzangleandproximaltothedistalthirdoftheileum
Behavior •B1:notstenoticandnon-penetrating•B2:stenotic•B3:Penetrating•B2B3:bothpenetratingandstenosing•p:perinealdisease
Growth•G0:noevidenceofstunting•G1:withevidenceofgrowthdeficit
gestivesymptomsandradiologicalassessmentofseeminglynormalsmallintestine.TheEndo-scopeCapsulemaynotbeperformedinthepresenceofintestinalstenosis,asinthesecasesthecapsulecanberetainedinplace.Toruleoutthispossibility,onecanusepriortotheexamina-tion,acompositeofbiodegradablematerialcapsule,thesamesizeasusedfortheexamination.Ifitisexcretedintact,thepatencyoftheintestinallumenwillbeconfirmed,enablingthefinalcompletionofthecapsuleendoscope,ontheotherhand,ifthereisimpactionofthecapsuleinastenosedintestinalsegment,itwilldisintegratein40hoursduetotheactionofintestinalfluid[1].
Theexploratorylaparoscopymaybeusefulinselectedcasespatients,forexample,whenthereispossibilityofintestinaltuberculosis[1,2].
8. The classification of Paris
TheclassificationofParis[32],recentlyupdated,tocharacterizethepatientwithCDaccordingtoageatdiagnosis,locationofthedisease,inflammationbehavior.Itshouldbeap-pliedintheinitialstagingandprogressionofthedisease,andthisdetailedinTable 5.Asanadaptationtopediatricpractice,wasaddedtothediscriminatoryphenotypecharacteristicitwassubdividedaccordingtowhetherthediseasewasdiagnosedbeforeorafterthepatientwas10yearsold,thepresenceorabsenceofgrowthfailure,alsointroducedsubdivisionofuppergastrointestinaldiseaseintojejunalversusoesophago-gastro-duodenaldisease.Thedemarca-tionofthediseaseterritoryshouldbeguidedbyinflammationobservedatendoscopyorimag-ingandnotbymicroscopicInvolvement.
ThephenotypepediatricCDCharacterizedbymorewidespread intestinal inflamma-tion,oftenInvolvingthelargeandsmallbowelaswellastheuppergastrointestinaltract(pa-
InflammatoryBowelDisease
11
n-entericdisease)[8].
9. Conclusion
TheCDhasbecomeanincreasinglydiagnosedinchildrenofallages.Thisconditionisofparticularclinicalpictureinchildrencomparedwithadults.Performearlydiagnosisiscru-cialtoavoidanadditionalimpactonthenutritionalstatus,growingandpubertaldevelopment.ItalsorequiresattentiontotheconsequencesofCDonthepsychosocialaspectofchildrenandadolescents,asiscommoninCDschoolbreakandsocialactivities,especiallyinthosepatientswithunstableorseveredisease,requiringpsychologicalintervention.
10. References
1.LevineA,KoletzkoS,DTurner,EscherJC,CucchiaraS,deRidderL,KolloKL,etal.EuropeanSocietyofPediatricGastroenterology,Hepatology,andNutrition.ESPGHANPortrevisedcriteriaforthediagnosisofinflammatoryboweldiseaseinchildrenandadolescents.J.PediatricGastroenterolNutr2014;58(6):795-806.
2.RosenM,DhawanA,SaeedSA.InflammatoryBowelDiseaseinChildrenandAdolescents.JAMAPediatrics2015,169(11):1053-1060.
3.BehrensR,SBuderus,FindeisenTheHauerTheKellerKMetal.ChildhoodOnsetInflammatoryBowelDisease:PredictorsofDelayedDiagnosisfromtheCEDATAGerman-LanguagePediatricInflammatoryBowelDiseaseRegistry.JPediatr.2011;158:467-473.
4.AuvinS,MolinieF,Gower-RousseauC,FBrazier,MerleV,GrandbastienB,etal.Incidence,clinicalpresentationandlocationatdiagnosisofpediatricinflammatoryboweldisease:aprospectivepopulation-basedstudyinnorthernFrance(1988-1999).JPediatrGastroenterolNutr.2005;41:49-55.977-980.
5.BentsenBS,MoumB,EkbomA.IncidenceofinflammatoryboweldiseaseinchildreninsoutheasternNorway:aprospectivepopulation-basedstudy1990-94.ScandJGastroenterol.2002;37:540-545.
6.CastroF,PapadatouB,BaldassareM,FBalli,TheBarabino,BarberaC.,etal.Inflammatoryboweldiseaseinchil-drenandadolescentsinItaly:datafromtheNationalPediatricIBDregister(1996-2003).InflammBowelDis.2008;14:1246-1252.
7.BieCL,BuderusS,SandhuBKdeRidderLPaerregaardAVeresGetal.EuroKidsPortIBDWorkingGroupofES-PGHAN.DiagnosticworkupofpediatricPatientswithinflammatoryboweldiseaseinEurope:resultsofa5-yearauditoftheEuroKidsregistry.JPediatrGastroenterolNutr.2012;54(3):374-380.
8.MalmborgP&HHildebrandTheemergingglobalepidemicofpediatricinflammatoryboweldisease-causesandconsequências.JInternMed.2016;279:241-258.
9.CostaCOPC,CarrilhoFJ,NunesVS,SipahiAM,RodriguesM.AsnapshotofthenutritionalstatusofCrohn’sdiseaseAmongadolescentsinBrazil:aprospectivecross-sectionalstudy.BMCGastroenterology.2015;15:172.
10.KotlarzD,BeierR,DMuruga,DiestelhorstJ,Jensen,BoztugKetal.LossofInterleukin-10SignalingandInfantileInflammatoryBowelDisease:ImplicationsforTherapyandDiagnosis.Gastroenterol.2012;143:347-355.
11.ShahN,KammermeierJElawadMGlockerEO.Interleukin-10andInterleukin-10-ReceptorDefectsinInflamma-toryBowelDisease.CurrAllergyAsthmaRep.2012;12:373-379.
12.ShimaOJ,HwangaS,YangaHR,MoonaJS,ChangaJY,KoaJSetal.Interleukin-10receptormutationsinchildrenwithneonatalonsetCrohn’sdiseaseandintractableulceratingenterocolitis.EuropeanJournalofGastroenterology&Hepatology.2013;25(10):1235-1240.
InflammatoryBowelDisease
12
13.MuiseAM,SnapperSB,KugathasabS.TheAgeofGeneDiscoveryinVeryEarlyOnsetInflammatoryBowelDis-ease.Gastroenterology.2012;143(2):285-288.
14.KugathasanS,JuddRH,RGHoffmanetalWisconsinPediatricInflammatoryBowelDiseaseAlliance.Epidemiolog-icandClinicalcharacteristicsofchildrenwithnewlydiagnosedinflammatoryboweldiseaseinWisconsin:astatewidepopulation-basedstudy.JPediatr.2003;143(4):525-531.
15.GriffithsAM.Specifitiesofinflammatoryboweldiseaseinchildhood.BestPractResClinGastroenterol.2004;18(3):509-523.
16.TheSawczenko,SandhuBK.PresentingfeaturesofinflammatoryboweldiseaseinGreatBritainandIreland.ArchDisChild.203;88(11):995-1000.
17.JoseFA,HeymanMB.Extraintestinalmanifestationsofinflammatoryboweldisease.JPediatrGastroenterolNutr.2008;46(2):124-133.
18.BousvarosAAntonioliDA,CollettiRB,DubinskyMC,GlickmanJN,GoldBD,etal.DifferentiatingulcerativecolitisfromCrohn’sdiseaseinchildrenandyoungadults:reportoftheworkinggroupoftheNorthAmericanSocietyforPediatricGastroenterology,Hepatology,andNutritionandtheCrohn’sandColitisFoundationofAmerica.JPedia-trGastroenterolNutr.2007;44(5):653-674.
19.El-ChammasK,MajeskieA,SimpsonP,SoodM,MirandaA.RedFlagsinChildrenwithChronicAbdominalPainandCrohn’sDisease-ASingleCenterExperience.JPediatr.2013;162:783-787.
20.Tanner,J.M.Growthatadolescence.2nd.ed.Oxford:BlackwellScientific,1962.
21.BunnSK,BissetWM,MainMJ,GrayES,OlsonS,GoldenBE.Fecalcalprotectin:validationasanoninvasivemea-sureofbowelinflammationinchildhoodinflammatoryboweldisease.JPediatrGastroenterolNutr.2001;33(1):14-22.
22.HoltmanGA,vanLeeuwenLisman-Y,ReitsmaJB,BergerMY.NoninvasiveTestsforInflammatoryBowelDisease:AMeta-analysis.Pediatrics.2016;137(1):1-11.
23.CarroccioT,IaconoL,MCottoneDiPressL,CartabellottaF,FCavataioetal.Diagnosticaccuracyoffecalcalpro-tectinassayindistinguishingorganiccausesofchronicdiarrheafromirritablebowelsyndrome:aprospectivestudyinadultsandchildren.ClinChem.2003;49(6):861-867.
24.KovácsM,MullerKE,PappM,LakatosPL,CsondesM,G.VeresNewserologicalmarkersinpediatricPatientswithinflammatoryboweldisease.WorldJGastroenterol.20147;20(17):4873-4882.
25.BogdanosDP,RoggenbuckD,ReinholdD,WexT,PavlidisP,vonArnimUetal.Pancreatic-specificautoantibodiestoglycoprotein2MirrordiseaselocationandbehaviorinyoungerPatientswithCrohn’sdisease.BMGGastroenterol-ogy.2012;12:102.
26.DegraeuwePL,BeldMP,AshornM,CananiRB,DayAS,DiamantA,FagerbergUL,HendersonPKolhoKL,VandeVijverAndvanRheenenPF,WilsonDC,KesselsAG.FaecalcalprotectininSuspectedpediatricinflammatoryboweldisease.JPediatrGastroenterol.2015;60(3):339-46.
27.MinarE,YHaberman,JurickovaI,etal.UtilityofneutrophilFc?Receptor(CD64)indexasabiomarkerformucosalinflammationinpediatricCrohn’sdisease.InflammBowelDis.2014;2016:1037-1048.
28.MackDRLangtonC,JMarkowitzetal.PediatricInflammatoryDiseaseCollaborativeResearchGroup.Laboratoryvaluesforchildrenwithnewlydiagnosedinflammatoryboweldisease.Pediatrics.2007;119(6):1113-1119.
29.BassJA,CAFriesen,DeasyAD,NeilanNA,BrakenJM.Investigationofpotentialearlyhistologicmarkersofpe-diatricinflammatoryboweldisease.BMCGastroenterology.2015;15:129.
30.SauerCG.Radiationexposure inchildrenwith inflammatoryboweldisease.CurrOpinPediatr.2012;24(5):621-
626.
31.HammerMR,PodbereskyDJ,DillmanJR.Multidetectorcomputedtomographicandmagneticresonanceenterog-raphyinchildren:stateoftheart.RadiolClinNorthAm.2013;51(4):615-636.
32.LevineA,GriffithsA,MarkowitzJ,WilsonDC,TurnerD,RussellRKetal.PediatricmodificationoftheMontrealclassificationforinflammatoryboweldisease:theParisclassification.InflammBowelDis.2011;17(6):1314-1321.
13
InflammatoryBowelDisease